Search

Your research
 

5 documents found for "Tamoxifen"

1. Predictive & Monitoring Biomarker

... by case basis. Improvements are urgently needed. The goal of our biomarker is to rationalize use of Tamoxifen to treat these two subtypes of cancer (66% failure rate), determining if patients are prone to ...

  • Home
  • > R&D
  • > Predictive & Monitoring Biomarker

2. Publications

... Payré B., Bernad J., Bosser I., Pipy B., Silvente-Poirot S., Favre G., Faye J. C., and Poirot M. Tamoxifen is a Potent Inhibitor of Cholesterol Esterification and Prevents the Formation of Foam Cells. J ...

3. Biomarkers

... of the product portfolio of Affichem. AF300 can be used to predict and to monitor efficacy of Tamoxifen ...

4. NCE

... are natural New Chemical Entities (NCE) discovered while studying the mechanism of action of Tamoxifen in INSERM lab of Dr Marc POIROT. These molecules are strong inducers of cell ...

5. Home

... and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. de Medina P, Paillasse MR, Ségala G, Marc Poirot M and Silvente-Poirot S. Proc ...

 
Biomarker - Drug design - Anticancer therapy - Cell differentiation - Receptor - Enzyme - Metabolism - Cancer - Deafness - Melanoma - Neurodegenerative disease - Medicinal chemistry - Biotechnology - First in class molecule - New Chemical Entities - Cholesterol - Tamoxifen - Immunotherapy - Exosome - Oncology - Dendritic cell - Theranostic - Diagnosis - Prognosis -